Russia Stocks End Flat as Energy and Retail Shares Show Mixed Performance 
Bank of Japan Poised for Historic Rate Hike as Inflation Pressures Persist 
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs 
U.S. Dollar Slips Near Two-Month Low as Markets Await Key Jobs Data and Central Bank Decisions 
Australian Consumer Sentiment Slumps in Early December as Inflation Fears Resurface 
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff 
Asian Currencies Trade Sideways as Dollar Weakens Ahead of Key U.S. Data 
Trump Sues BBC for Defamation Over Edited Capitol Riot Speech Clip 
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand 
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model 
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership 
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns 
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit 
New Zealand Budget Outlook Shows Prolonged Deficits Despite Economic Recovery Hopes 
Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges 
Canon went to court to challenge the EU's sanction related to its acquisition of Toshiba Medical Systems Corporation in 2016 but was defeated. With the decision, the European Union's General Court upheld the €28 million €28 million fine that was previously imposed on the company.
According to Reuters, Canon, a Japanese optical, imaging, and industrial products manufacturer, is now facing a hefty fine, and this was revealed on Wednesday, May 18. It was the second-top court in Europe that sustained the sanction that was originally handed down in 2019.
The European Commission stated in its 2019 decision that Canon violated the rules by the "warehousing" two-step transaction structure where an interim buyer has been assigned to buy the medical unit of Toshiba before it could actually obtain regulatory clearance from the EU's competition agency.
It was reported that under the EU merger regulations, companies that close a deal first without obtaining the EU regulatory approval could be fined by up to 10% of the deal price. The fine is also applicable if companies provide misleading information during the regulatory review.
This unusual method of acquisition allowed Toshiba to book proceeds just in time for the financial year-end ending in March. Originally, this would have been impossible because the company was cash-strapped due to its accounting scandal.
The EU competition slapped Canon with a fine for the said "warehousing," and this week, the Luxembourg-based General Court backed the decision. The judge said, "The European Commission was therefore right to observe that the Court's case-law distinguishes between the concepts of 'concentration' and 'implementation of a concentration.'"
Meanwhile, as previously reported by ITN News, Toshiba Medical Systems' name was changed to Canon Medical Systems Corp. after the acquisition was completed following the deal agreement in 2016.
Canon Inc. and Canon Medical Systems Corp. announced the new name of the newly-acquired company in January 2018. Canon Group was declared the winner in the bidding for the acquisition of CMS with its reported bid of $6.21 billion.
